Ferrara, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 350
EU - Europa 334
AS - Asia 206
SA - Sud America 22
AF - Africa 2
Totale 914
Nazione #
US - Stati Uniti d'America 346
RU - Federazione Russa 145
GB - Regno Unito 86
CN - Cina 81
SG - Singapore 62
IE - Irlanda 20
VN - Vietnam 19
HK - Hong Kong 18
SE - Svezia 18
IT - Italia 16
BR - Brasile 14
FR - Francia 14
DE - Germania 11
KR - Corea 8
FI - Finlandia 7
BD - Bangladesh 4
IN - India 4
NL - Olanda 4
CA - Canada 3
JP - Giappone 3
VE - Venezuela 3
AR - Argentina 2
AT - Austria 2
CL - Cile 2
ID - Indonesia 2
LT - Lituania 2
PL - Polonia 2
UA - Ucraina 2
AL - Albania 1
AZ - Azerbaigian 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
GA - Gabon 1
IQ - Iraq 1
MX - Messico 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PK - Pakistan 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 914
Città #
Chandler 81
Southend 79
Moscow 48
Dallas 41
Ashburn 34
Woodbridge 32
Singapore 28
San Jose 24
Dublin 20
Hong Kong 18
Beijing 17
Houston 11
New York 11
The Dalles 8
Ho Chi Minh City 6
Los Angeles 6
Nanjing 6
Verona 6
Wilmington 6
Jinan 5
Lawrence 5
Princeton 5
Shenyang 5
Buffalo 4
Columbus 4
Tianjin 4
Detroit 3
Hanoi 3
Montreal 3
Ningbo 3
Orem 3
Seoul 3
São Paulo 3
Taizhou 3
Tokyo 3
Turku 3
Augusta 2
Biên Hòa 2
Haikou 2
Hebei 2
Jakarta 2
London 2
Manchester 2
Marostica 2
Meda 2
Mumbai 2
Munich 2
Redondo Beach 2
Rio de Janeiro 2
Rosario 2
Salvador 2
Shanghai 2
Sindelfingen 2
Warsaw 2
Zhengzhou 2
Abuja 1
Amsterdam 1
Ann Arbor 1
Austin 1
Baku 1
Barnet 1
Barquisimeto 1
Birmingham 1
Brooklyn 1
Buon Ma Thuot 1
Charlotte 1
Chennai 1
Chicago 1
Colombo 1
Concepción 1
Delhi 1
Fortaleza 1
Fremont 1
Fuzhou 1
Guangzhou 1
Guarenas 1
Guiyang 1
Hamilton 1
Ibatiba 1
Ituiutaba 1
Kyiv 1
La Guaira 1
Lancaster 1
Libreville 1
Marseille 1
Mexico City 1
Milwaukee 1
Montes Claros 1
Nanchang 1
Narayanganj 1
Newark 1
Oceanside 1
Phoenix 1
Phú Thái 1
Piscataway 1
Portoviejo 1
Poções 1
Prague 1
Redwood City 1
Russellville 1
Totale 627
Nome #
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer 212
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 187
The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives 179
Adjuvant therapy for resected early-stage small-cell lung cancer: is now time to rethink about that? 174
Tubulin inhibitors in non-small cell lung cancer: looking back and forward 169
Totale 921
Categoria #
all - tutte 2.760
article - articoli 2.760
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.520


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 3 1
2021/202243 5 18 0 0 4 0 1 1 0 1 0 13
2022/2023141 6 15 5 57 11 31 0 8 7 0 1 0
2023/202447 1 4 2 2 7 13 0 5 1 6 5 1
2024/2025115 7 3 7 23 2 7 3 1 20 10 12 20
2025/2026390 23 21 41 63 109 21 34 20 34 24 0 0
Totale 921